Patents/Assignees

HANX BIOPHARMACEUTICS, Inc

2 patents in portfolio

US12195545utility2025
Anti-ox40 Monoclonal Antibody and Application Thereof
0 cites
US11680099utility2023
Anti-pd-1/cd47 Bispecific Antibody and Application Thereof
0 cites